Effectiveness of antitussive, anticholinergic and honey therapy versus usual practice in adults with uncomplicated acute bronchitis [AB4T study] - AB4T study

IDIAP Jordi Gol0 个研究点目标入组 668 人开始时间: 2018年8月10日最近更新: 2019年1月7日

适应症

试验速览

暂无简介。

•- Patients aged 18 years or older, who come to the primary care physician with cough of up to 3 weeks of evolution in the context of acute bronchitis and who agree to participate in the clinical trial.
•- Patients who score =4 in daytime and / or nighttime on the Likert scale of 6 points.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 508
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 160

•- Suspected pneumonia.
•- Patient with criteria for hospital referral
•- Pregnancy or lactation.
•- Basic respiratory disease: chronic obstructive pulmonary disease, asthma, tuberculosis or bronchiectasis.
•- Associated significant comorbility: moderate-severe heart failure, dementia, acute myocardial infarction / recent stroke (<3 months), severe hepatic insufficiency, severe renal insufficiency.
•- Immunosuppression.
•- Active neoplasia
•- Terminal disease
•- History of intolerance or allergy to any of the study treatments.
•- Patients in whom, in the opinion of the researcher, treatment with dextromethorphan, ipratropium bromide or honey is contraindicated.
•- Institutionalized patients.
•- Difficulty making scheduled follow-up visits.

发起方